Trial 4B-15-15


An Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Multi-Centre, Multi-arm Phase 1b Study in Patients with Muscle Invasive Bladder Cancer (MIBC) Who have Progressed on Prior Treatment (BISCAY)

Type: Treatment
Phase: Phase I/II
Status: Not Open (Never Opened)
Treatments: Immunotherapy
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  David Quinn, M.D.
Other Trial Staff:  Cheryl Kefauver, R.N., Vage Movsesyan, D.M., Lagrimas Ilagan, D.M., Roberto Tejada, D.M., Charis Barg, R.N., Bartolo Santos, R.N., Gina LaBeaud, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.